Trial
NCT03241719
Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
—
Condition
Amputation, Traumatic
Intervention
IL-2
Why stopped
No participants are currently receiving therapy under this protocol, funding is coming to an end and the PI is leaving the institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-28